Elicio Therapeutics, Inc. (ELTX) stock
ELTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.50−0.06 (-3.85%)
Close on Nov 13, 2026Market cap $39.42MP/E –Yield –
Elicio Therapeutics cash
Cash and short-term investments held at the end of each period.
Elicio Therapeutics's cash was $30.90M at Sep 30, 2026. For fiscal 2025 it was $18.56M, down 4.8% from the year before. The highest annual figure on record is $34.61M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.56M | -4.8% |
| FY2024 | Dec 31, 2024 | $19.49M | +36.3% |
| FY2023 | Dec 31, 2023 | $14.30M | +70.0% |
| FY2022 | Dec 31, 2022 | $8.41M | -16.2% |
| FY2021 | Dec 31, 2021 | $10.05M | -71.0% |
| FY2020 | Dec 31, 2020 | $34.61M | +521.2% |
| FY2019 | Dec 31, 2019 | $5.57M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $30.90M | +49.9% |
| Q2 FY2026 | Jun 30, 2026 | $23.48M | +6.3% |
| Q1 FY2026 | Mar 31, 2026 | $14.95M | -18.5% |
| Q4 FY2025 | Dec 31, 2025 | $18.56M | -4.8% |
| Q3 FY2025 | Sep 30, 2025 | $20.61M | -20.8% |
| Q2 FY2025 | Jun 30, 2025 | $22.09M | +544.9% |
| Q1 FY2025 | Mar 31, 2025 | $18.35M | +54.8% |
| Q4 FY2024 | Dec 31, 2024 | $19.49M | +36.3% |
| Q3 FY2024 | Sep 30, 2024 | $26.02M | +75.3% |
| Q2 FY2024 | Jun 30, 2024 | $3.43M | -84.2% |
| Q1 FY2024 | Mar 31, 2024 | $11.85M | +38.3% |
| Q4 FY2023 | Dec 31, 2023 | $14.30M | +70.0% |
| Q3 FY2023 | Sep 30, 2023 | $14.84M | +707.0% |
| Q2 FY2023 | Jun 30, 2023 | $21.68M | +3525.8% |
| Q1 FY2023 | Mar 31, 2023 | $8.57M | -88.3% |
| Q4 FY2022 | Dec 31, 2022 | $8.41M | -16.2% |
| Q3 FY2022 | Sep 30, 2022 | $1.84M | -98.2% |
| Q2 FY2022 | Jun 30, 2022 | $598.00K | -99.5% |
| Q1 FY2022 | Mar 31, 2022 | $73.00M | -44.0% |
| Q4 FY2021 | Dec 31, 2021 | $10.05M | -71.0% |
| Q3 FY2021 | Sep 30, 2021 | $102.74M | +628.1% |
| Q2 FY2021 | Jun 30, 2021 | $117.31M | +2227.2% |
| Q1 FY2021 | Mar 31, 2021 | $130.46M | +13117.4% |
| Q4 FY2020 | Dec 31, 2020 | $34.61M | +521.2% |
| Q3 FY2020 | Sep 30, 2020 | $14.11M | – |
| Q2 FY2020 | Jun 30, 2020 | $5.04M | – |
| Q1 FY2020 | Mar 31, 2020 | $987.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $5.57M | – |
See a number that looks wrong?